116 related articles for article (PubMed ID: 2008104)
1. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits.
Videm V; Mollnes TE; Garred P; Svennevig JL
J Thorac Cardiovasc Surg; 1991 Apr; 101(4):654-60. PubMed ID: 2008104
[TBL] [Abstract][Full Text] [Related]
2. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of new surface coatings for extracorporeal circulation.
Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL
Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642
[TBL] [Abstract][Full Text] [Related]
4. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
6. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
Kirschfink M; Kovacs B; Mottaghy K
Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
Borowiec JW; Venge P; Henze A; Nilsson B; Stiernström H
Thorac Cardiovasc Surg; 1997 Dec; 45(6):295-301. PubMed ID: 9477462
[TBL] [Abstract][Full Text] [Related]
9. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
10. Platelet compatibility of an artificial surface modified with functionally active heparin.
Mollnes TE; Videm V; Christiansen D; Bergseth G; Riesenfeld J; Hovig T
Thromb Haemost; 1999 Sep; 82(3):1132-6. PubMed ID: 10494777
[TBL] [Abstract][Full Text] [Related]
11. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
[TBL] [Abstract][Full Text] [Related]
12. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
[TBL] [Abstract][Full Text] [Related]
13. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfaces.
Kopp R; Mottaghy K; Kirschfink M
ASAIO J; 2002; 48(6):598-605. PubMed ID: 12455769
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants.
Böning A; Scheewe J; Ivers T; Friedrich C; Stieh J; Freitag S; Cremer JT
J Thorac Cardiovasc Surg; 2004 May; 127(5):1458-65. PubMed ID: 15116008
[TBL] [Abstract][Full Text] [Related]
16. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery.
Hoel TN; Thiara AS; Videm V; Fiane AE; Mollnes TE; Castellheim A; Svennevig JL
Scand Cardiovasc J; 2009 Apr; 43(2):129-35. PubMed ID: 19294579
[TBL] [Abstract][Full Text] [Related]
18. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
19. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
20. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]